
The study is expected to cost C$2.7 million and will run for three months.
The study is expected to cost C$2.7 million and will run for three months.
The company received $8.6 million in funding from Cantheon Capital LLC.
Unpack the industry with the daily cannabis newsletter for business leaders.
Unpack the industry with the daily cannabis newsletter for business leaders.